10x Genomics
TXG
10x Genomics (TXG) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Stephens & Co. | Maintained | Overweight | $65.00 from $50.00 | Aug 12, 2026 |
| Canaccord Genuity | Maintained | Buy | $60.00 from $50.00 | Aug 10, 2026 |
| Piper Sandler | Maintained | Neutral | $47.00 from $42.00 | Aug 10, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $40.00 from $37.00 | Aug 7, 2026 |
| Citigroup | Maintained | Neutral | $50.00 from $45.00 | Aug 7, 2026 |
| Leerink Partners | Maintained | Market Perform | $40.00 from $23.00 | Jul 17, 2026 |
| Canaccord Genuity | Maintained | Buy | $50.00 from $32.00 | Jul 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $37.00 from $22.00 | Jul 9, 2026 |
| Citigroup | Maintained | Neutral | $45.00 from $24.00 | Jul 8, 2026 |
| Piper Sandler | Maintained | Neutral | $42.00 from $20.00 | Jul 1, 2026 |
| Barclays | Maintained | Overweight | $40.00 from $30.00 | Jun 24, 2026 |
| JP Morgan | Maintained | Neutral | $20.00 from $17.00 | May 12, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $22.00 from $20.00 | May 12, 2026 |
| B of A Securities | Maintained | Neutral | $30.00 from $21.00 | Apr 20, 2026 |
| Canaccord Genuity | Maintained | Buy | $32.00 from $22.00 | Apr 20, 2026 |
| Barclays | Maintained | Overweight | $30.00 from $22.00 | Apr 14, 2026 |
| Citigroup | Maintained | Neutral | $24.00 from $18.00 | Apr 7, 2026 |
| William Blair | Upgraded | Market Perform → Outperform | — | Mar 31, 2026 |
| Stifel | Maintained | Buy | $25.00 from $20.00 | Mar 2, 2026 |
| UBS | Maintained | Neutral | $20.00 from $14.00 | Feb 20, 2026 |
Frequently asked questions
What is the latest analyst rating on TXG?
On Aug 12, 2026, Stephens & Co. maintained 10x Genomics at Overweight with a price target of $65.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.